Company Number: 12798992

Analysis Date: 2025-07-20 16:38 UTC

1. Credit Opinion: APPROVE
   Creative Cure Ltd demonstrates a stable and positive financial position with consistent growth in net assets over the last four years. The company maintains a healthy net current asset position, indicating good short-term liquidity and ability to meet current obligations. The absence of overdue filings and the sole director’s full ownership enhance transparency and accountability. Given the micro-entity scale and modest liabilities, the risk profile is low, supporting approval for credit facilities.

2. Financial Strength:
   The balance sheet shows net assets growing from £5,997 in 2021 to £25,013 in 2024, reflecting retained earnings accumulation and conservative financial management. Fixed assets are minimal (£748 in 2024), consistent with a consultancy business model reliant on intellectual capital rather than heavy investment in physical assets. Current assets (£54,555) exceed current liabilities (£30,290) by a solid margin, demonstrating working capital adequacy. Shareholders’ funds equate to net assets, with no indication of external debt, signaling low leverage and financial resilience.

3. Cash Flow Assessment:
   The company’s working capital has improved from £4,667 in 2021 to £24,265 in 2024, suggesting enhanced liquidity and operational cash flow management. The increase in current assets, primarily cash or receivables, relative to liabilities implies the company can comfortably service short-term debts. Although detailed cash flow statements are unavailable, the stable net current assets and absence of external borrowings indicate sufficient internal funds to cover operating needs and potential credit commitments.

4. Monitoring Points:

• Monitor receivables turnover and debtor aging to ensure liquidity remains strong.
• Watch for any significant changes in current liabilities that might pressure working capital.
• Review management of operating expenses and profitability trends once profit and loss data is available to assess earnings sustainability.
• Maintain oversight on director’s conduct and any changes in ownership or control that might affect governance.